世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4077
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、皮膚線維症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化薬、免疫グロブリン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・皮膚線維症治療薬の市場動向
・企業の競争状況、市場シェア
・皮膚線維症治療薬の種類別市場規模と予測2016-2027（コルチコステロイド、抗線維化薬、免疫グロブリン）
・皮膚線維症治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・皮膚線維症治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・皮膚線維症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・皮膚線維症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・皮膚線維症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・皮膚線維症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Sanofi、Merck、Roche、GlaxoSmithKline、Bayer、Boehringer Ingelheim、Horizon Pharma、Bristol-Myers Squibb）
・結論

Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extracellular matrix proteins by dermal fibroblasts.
Cutaneous Fibrosis Drugs as treatment of cutaneous fibrosis, the goal of skin fibrosis treatment is the restore abnormally activated dermal fibroblasts producing the excessive amount of extracellular matrix, which is generally a final consequence of the complex disease process including the activation of vascular and immune systems.

Market Analysis and Insights: Global Cutaneous Fibrosis Drugs Market
The global Cutaneous Fibrosis Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Fibrosis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Fibrosis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Fibrosis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Fibrosis Drugs market.

Global Cutaneous Fibrosis Drugs Scope and Market Size
Cutaneous Fibrosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Fibrosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Anti-Fibrotic Drugs
Immunoglobulins

Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Sanofi
Merck
Roche
GlaxoSmithKline
Bayer
Boehringer Ingelheim
Horizon Pharma
Bristol-Myers Squibb

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Fibrosis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Anti-Fibrotic Drugs
1.2.4 Immunoglobulins
1.3 Market by Application
1.3.1 Global Cutaneous Fibrosis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cutaneous Fibrosis Drugs Market Perspective (2016-2027)
2.2 Cutaneous Fibrosis Drugs Growth Trends by Regions
2.2.1 Cutaneous Fibrosis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Fibrosis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Fibrosis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Fibrosis Drugs Industry Dynamic
2.3.1 Cutaneous Fibrosis Drugs Market Trends
2.3.2 Cutaneous Fibrosis Drugs Market Drivers
2.3.3 Cutaneous Fibrosis Drugs Market Challenges
2.3.4 Cutaneous Fibrosis Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Fibrosis Drugs Players by Revenue
3.1.1 Global Top Cutaneous Fibrosis Drugs Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Fibrosis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Fibrosis Drugs Revenue
3.4 Global Cutaneous Fibrosis Drugs Market Concentration Ratio
3.4.1 Global Cutaneous Fibrosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Fibrosis Drugs Revenue in 2020
3.5 Cutaneous Fibrosis Drugs Key Players Head office and Area Served
3.6 Key Players Cutaneous Fibrosis Drugs Product Solution and Service
3.7 Date of Enter into Cutaneous Fibrosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cutaneous Fibrosis Drugs Breakdown Data by Type
4.1 Global Cutaneous Fibrosis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Fibrosis Drugs Forecasted Market Size by Type (2022-2027)

5 Cutaneous Fibrosis Drugs Breakdown Data by Application
5.1 Global Cutaneous Fibrosis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Fibrosis Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cutaneous Fibrosis Drugs Market Size (2016-2027)
6.2 North America Cutaneous Fibrosis Drugs Market Size by Type
6.2.1 North America Cutaneous Fibrosis Drugs Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Fibrosis Drugs Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Fibrosis Drugs Market Size by Type (2016-2027)
6.3 North America Cutaneous Fibrosis Drugs Market Size by Application
6.3.1 North America Cutaneous Fibrosis Drugs Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Fibrosis Drugs Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Fibrosis Drugs Market Size by Application (2016-2027)
6.4 North America Cutaneous Fibrosis Drugs Market Size by Country
6.4.1 North America Cutaneous Fibrosis Drugs Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Fibrosis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cutaneous Fibrosis Drugs Market Size (2016-2027)
7.2 Europe Cutaneous Fibrosis Drugs Market Size by Type
7.2.1 Europe Cutaneous Fibrosis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Fibrosis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Fibrosis Drugs Market Size by Type (2016-2027)
7.3 Europe Cutaneous Fibrosis Drugs Market Size by Application
7.3.1 Europe Cutaneous Fibrosis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Fibrosis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Fibrosis Drugs Market Size by Application (2016-2027)
7.4 Europe Cutaneous Fibrosis Drugs Market Size by Country
7.4.1 Europe Cutaneous Fibrosis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Fibrosis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Fibrosis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type
8.2.1 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application
8.3.1 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Region
8.4.1 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cutaneous Fibrosis Drugs Market Size (2016-2027)
9.2 Latin America Cutaneous Fibrosis Drugs Market Size by Type
9.2.1 Latin America Cutaneous Fibrosis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Fibrosis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Fibrosis Drugs Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Fibrosis Drugs Market Size by Application
9.3.1 Latin America Cutaneous Fibrosis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Fibrosis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Fibrosis Drugs Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Fibrosis Drugs Market Size by Country
9.4.1 Latin America Cutaneous Fibrosis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Fibrosis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Fibrosis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type
10.2.1 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application
10.3.1 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Country
10.4.1 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cutaneous Fibrosis Drugs Introduction
11.1.4 Pfizer Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cutaneous Fibrosis Drugs Introduction
11.2.4 Novartis Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Cutaneous Fibrosis Drugs Introduction
11.3.4 Sanofi Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cutaneous Fibrosis Drugs Introduction
11.4.4 Merck Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cutaneous Fibrosis Drugs Introduction
11.5.4 Roche Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Cutaneous Fibrosis Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Cutaneous Fibrosis Drugs Introduction
11.7.4 Bayer Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Cutaneous Fibrosis Drugs Introduction
11.8.4 Boehringer Ingelheim Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Horizon Pharma
11.9.1 Horizon Pharma Company Details
11.9.2 Horizon Pharma Business Overview
11.9.3 Horizon Pharma Cutaneous Fibrosis Drugs Introduction
11.9.4 Horizon Pharma Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.9.5 Horizon Pharma Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Cutaneous Fibrosis Drugs Introduction
11.10.4 Bristol-Myers Squibb Revenue in Cutaneous Fibrosis Drugs Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cutaneous Fibrosis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Anti-Fibrotic Drugs
Table 4. Key Players of Immunoglobulins
Table 5. Global Cutaneous Fibrosis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cutaneous Fibrosis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cutaneous Fibrosis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cutaneous Fibrosis Drugs Market Share by Regions (2016-2021)
Table 9. Global Cutaneous Fibrosis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cutaneous Fibrosis Drugs Market Share by Regions (2022-2027)
Table 11. Cutaneous Fibrosis Drugs Market Trends
Table 12. Cutaneous Fibrosis Drugs Market Drivers
Table 13. Cutaneous Fibrosis Drugs Market Challenges
Table 14. Cutaneous Fibrosis Drugs Market Restraints
Table 15. Global Cutaneous Fibrosis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cutaneous Fibrosis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Cutaneous Fibrosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Fibrosis Drugs as of 2020)
Table 18. Ranking of Global Top Cutaneous Fibrosis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cutaneous Fibrosis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cutaneous Fibrosis Drugs Product Solution and Service
Table 22. Date of Enter into Cutaneous Fibrosis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cutaneous Fibrosis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Cutaneous Fibrosis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cutaneous Fibrosis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cutaneous Fibrosis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cutaneous Fibrosis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Cutaneous Fibrosis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cutaneous Fibrosis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cutaneous Fibrosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cutaneous Fibrosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cutaneous Fibrosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cutaneous Fibrosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cutaneous Fibrosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cutaneous Fibrosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cutaneous Fibrosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cutaneous Fibrosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cutaneous Fibrosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cutaneous Fibrosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cutaneous Fibrosis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cutaneous Fibrosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cutaneous Fibrosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cutaneous Fibrosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cutaneous Fibrosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cutaneous Fibrosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cutaneous Fibrosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Cutaneous Fibrosis Drugs Product
Table 65. Pfizer Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Cutaneous Fibrosis Drugs Product
Table 70. Novartis Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Cutaneous Fibrosis Drugs Product
Table 75. Sanofi Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Cutaneous Fibrosis Drugs Product
Table 80. Merck Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Cutaneous Fibrosis Drugs Product
Table 85. Roche Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Cutaneous Fibrosis Drugs Product
Table 90. GlaxoSmithKline Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Cutaneous Fibrosis Drugs Product
Table 95. Bayer Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 96. Bayer Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 100. Boehringer Ingelheim Recent Development
Table 101. Horizon Pharma Company Details
Table 102. Horizon Pharma Business Overview
Table 103. Horizon Pharma Cutaneous Fibrosis Drugs Product
Table 104. Horizon Pharma Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 105. Horizon Pharma Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Cutaneous Fibrosis Drugs Product
Table 109. Bristol-Myers Squibb Revenue in Cutaneous Fibrosis Drugs Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Fibrosis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Anti-Fibrotic Drugs Features
Figure 4. Immunoglobulins Features
Figure 5. Global Cutaneous Fibrosis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Cutaneous Fibrosis Drugs Report Years Considered
Figure 10. Global Cutaneous Fibrosis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cutaneous Fibrosis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cutaneous Fibrosis Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Cutaneous Fibrosis Drugs Market Share by Regions (2022-2027)
Figure 14. Global Cutaneous Fibrosis Drugs Market Share by Players in 2020
Figure 15. Global Top Cutaneous Fibrosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Fibrosis Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cutaneous Fibrosis Drugs Revenue in 2020
Figure 17. Global Cutaneous Fibrosis Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Cutaneous Fibrosis Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cutaneous Fibrosis Drugs Market Share by Type (2016-2027)
Figure 21. North America Cutaneous Fibrosis Drugs Market Share by Application (2016-2027)
Figure 22. North America Cutaneous Fibrosis Drugs Market Share by Country (2016-2027)
Figure 23. United States Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cutaneous Fibrosis Drugs Market Share by Type (2016-2027)
Figure 27. Europe Cutaneous Fibrosis Drugs Market Share by Application (2016-2027)
Figure 28. Europe Cutaneous Fibrosis Drugs Market Share by Country (2016-2027)
Figure 29. Germany Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cutaneous Fibrosis Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cutaneous Fibrosis Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cutaneous Fibrosis Drugs Market Share by Region (2016-2027)
Figure 39. China Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cutaneous Fibrosis Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Cutaneous Fibrosis Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Cutaneous Fibrosis Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cutaneous Fibrosis Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cutaneous Fibrosis Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cutaneous Fibrosis Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cutaneous Fibrosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 65. Boehringer Ingelheim Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 66. Horizon Pharma Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Cutaneous Fibrosis Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4083 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚放射線障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ヒスタミン薬、抗生物質、コルチコステロイド、その他）、用途別市場規模（病院、診療所、外来外科センター、その他...

世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4079 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、皮膚エリテマトーデス（CLE）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ヒスタミン薬、抗生物質、コルチコステロイド、その他）、用途別市場規模（病院、診療所、外来外科...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027
QFJ1-4082 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の皮膚線維症治療市場規模・現状・予測（2021年-2027年）

Global Treatment of Skin Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-6052 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化剤、免疫療法薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の皮角治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Horn Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4078 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、皮角治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドラッグ、レーザーデバイス）、用途別市場規模（小売薬局、ドラッグストア、Eコマース、病院、専門クリニック、その他）、主要地域別市場規模（北米、ア...

世界の皮膚肥満細胞症治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Mastocytosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4081 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、皮膚肥満細胞症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗ヒスタミン薬、コルチコステロイド、肥満細胞安定剤、交感神経刺激薬（エフィネフリン）、光線化学療法）、用途別市場規模（病院、診療所、そ...

世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Squamous Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4084 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚扁平上皮がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、非外科的治療）、用途別市場規模（病院、がん研究所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4085 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚T細胞リンパ腫（CTCL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要...

世界の非嚢胞性線維症気管支拡張症市場規模・現状・予測（2021年-2027年）

Global Non-Cystic Fibrosis Bronchiectasis Market Size, Status and Forecast 2021-2027
QFJ1-4587 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、非嚢胞性線維症気管支拡張症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年） Cutaneous radiation injury occurs on a functional, cellular, and gross level. Radiation therapy is the major modality in the management of cancer treatment along with the surgery and chemotherapy. Most common side effect of the radiation is the acute skin reaction which usually range from mild to co…
世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Radiation Injury Treatment Market The global Cutaneous Radiation Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Lupus Erythematosus (CLE) Treatment Market The global Cutaneous Lupus Erythematosus (CLE) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
世界の皮膚肥満細胞症治療市場規模・現状・予測（2021年-2027年） Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis. Market Analysis and Insights: Gl…
世界の皮角治療市場規模・現状・予測（2021年-2027年） Cutaneous horn (Cornu cutaneum) is an adequately undynamic projectile, asymmetrical, hyperkeratosis bump. It is a typical type of non-melanoma skin cancer. Although 60% of the cutaneous horns are not harmful in nature, the probability of skin cancer is going to occur. Excisional biopsy is adequate f…